01. Gene therapy Boulikas.pdf - Gene therapy & Molecular Biology

Xiao X, Xiao W, Li J, Samulski RJ (1997) A novel 165-base-pair
terminal repeat sequence is the sole cis requirement for the
adeno-associated virus life cycle. J Virol 71, 941-948.
Xing X, Liu V, Xia W, Stephens LC, Huang L, Lopez-Berestein
G, Hung MC (1997) Safety studies of the intraperitoneal
injection of E1A--liposome complex in mice. Gene Ther 4,
238-243.
Xing Z, Tremblay GM, Sime PJ, Gauldie J (1997)
Overexpression of granulocyte-macrophage colonystimulating
factor induces pulmonary granulation tissue
formation and fibrosis by induction of transforming growth
factor-β1 and myofibroblast accumulation. Am J Pathol
150, 59-66.
Yamamoto R, Murakami K, Taira K, and Kumar PKR (1998)
Isolation and characterization of an RNA that binds with
high affinity to Tat protein of HIV-1 from a completely
random pool of RNA. Gene Ther Mol Biol 1, 451-466.
Yamamoto S, Suzuki S, Hoshino A, Akimoto M, Shimada T
(1997) Herpes simplex virus thymidine kinase/ganciclovirmediated
killing of tumor cell induces tumor-specific
cytotoxic T cells in mice. Cancer Gene Ther 4, 91-96.
Yamanaka S, Balestra ME, Ferrell LD, Fan J, Arnold KS, Taylor
S, Taylor JM, Innerarity TL (1995) Apolipoprotein B
mRNA-editing protein induces hepatocellular carcinoma and
dysplasia in transgenic animals. Proc Natl Acad Sci USA
92, 8483-8487.
Yang AG, Bai X, Huang XF, Yao C, Chen S (1997) Phenotypic
knockout of HIV type 1 chemokine coreceptor CCR-5 by
intrakines as potential therapeutic approach for HIV-1
infection. Proc Natl Acad Sci USA 94, 11567-11572.
Yang C, Cirielli C, Capogrossi MC, and Passaniti A (1995)
Adenovirus-mediated wild-type p53 expression induces
apoptosis and suppresses tumorigenesis of prostatic tumor
cells. Cancer Res 55, 4210-4213.
Yang CC, Xiao X, Zhu X, Ansardi DC, Epstein ND, Frey MR,
Matera AG, Samulski RJ (1997) Cellular recombination
pathways and viral terminal repeat hairpin structures are
sufficient for adeno-associated virus integration in vivo and
in vitro. J Virol 71, 9231-9247.
Yang JP and Huang L (1997) Overcoming the inhibitory effect
of serum on lipofection by increasing the charge ratio of
cationic liposome to DNA. Gene Ther 4, 950-960.
Yang Y, Li Q, Ertl HC, and Wilson JM (1995) Cellular and
humoral immune responses to viral antigens create barriers
to lung-directed gene therapy with recombinant
adenoviruses. J Virol 69, 2004-2015.
Yang Y, Nunes FA, Berencsi K, Furth EE, Gonczol E, and
Wilson JM (1994a) Cellular immunity to viral antigens
limits E1-deleted adenoviruses for gene therapy. Proc Natl
Acad Sci USA 91, 4407-4411.
Yang Y, Nunes FA, Berencsi K, Gonczol E, Engelhardt JF,
Wilson JM (1994b) Inactivation of E2a in recombinant
adenoviruses improves the prospect for gene therapy in
cystic fibrosis. Nat Genet 7, 362-369.
Yang Y, Vanin EF, Whitt MA, Fornerod M, Zwart R,
Schneiderman RD, Grosveld G, Nienhuis AW (1995)
Inducible, high-level production of infectious murine
leukemia retroviral vector particles pseudotyped with
Boulikas: An overview on gene therapy
162
vesicular stomatitis virus G envelope protein. Hum Gene
Ther 6, 1203-1213.
Yang Z-Y, Perkins ND, Ohno T, Nabel EG, Nabel GJ (1995)
The p21 cyclin-dependent kinase inhibitor suppresses
tumorigenicity in vivo. Nature Med 1, 1052-1056.
Yang ZY, Simari RD, Perkins ND, San H, Gordon D, Nabel GJ,
Nabel EG (1996) Role of the p21 cyclin-dependent kinase
inhibitor in limiting intimal cell proliferation in response to
arterial injury. Proc Natl Acad Sci USA 93, 7905-7910.
Yanofsky SD, Baldwin DN, Butler JH, Holden FR, Jacobs JW,
Balasubramanian P, Chinn JP, Cwirla SE, Peters-Bhatt E,
Whitehorn EA, Tate EH, Akeson A, Bowlin TL, Dower WJ,
Barrett RW (1996) High affinity type I interleukin 1 receptor
antagonists discovered by screening recombinant peptide
libraries. Proc Natl Acad Sci USA 93, 7381-7386.
Yao SN, Smith KJ, Kurachi K (1994) Primary myoblastmediated
gene transfer: persistent expression of human factor
IX in mice. Gene Ther 1, 99-107.
Yee JK, Miyanohara A, LaPorte P, Bouic K, Burns JC,
Friedmann T (1994) A general method for the generation of
high-titer, pantropic retroviral vectors: highly efficient
infection of primary hepatocytes. Proc Natl Acad Sci USA
91, 9564-9568.
Yew NS, Wysokenski DM, Wang KX, Ziegler RJ, Marshall J,
McNeilly D, Cherry M, Osburn W, Cheng SH (1997)
Optimization of plasmid vectors for high-level expression in
lung epithelial cells. Hum Gene Ther 8, 575-584.
Yew PR and Berk AJ (1992) Inhibition of p53 transactivation
required for transformation by adenovirus early 1B protein.
Nature 357, 82-85.
Ylä-Herttuala S (1996) Gene therapy for cardiovascular diseases.
Ann Med 28, 89-93.
Yokoyama Y, Takahashi Y, Morishita S, Hashimoto M, Tamaya
T (1997) Introduction of p21(Waf1/Cip1) gene into a
carcinoma cell line of the uterine cervix with inactivated p53.
Cancer Lett 116, 233-239.
Yonish-Rouach E, Grunwald D, Wilder S, Kimchi A, May E,
Lawrence J-J, May P, and Oren M (1993) p53-mediated cell
death: relationship to cell cycle control. Mol Cell Biol 13,
1415-1423.
Yoshimura K, Rosenfeld MA, Nakamura H, Scherer EM,
Pavirani A, Lecocq J-P, Crystal RG (1992) Expression of the
human cystic fibrosis transmembrane conductance regulator
gene in the mouse lung after in vivo intratracheal plasmidmediated
gene transfer. Nucleic Acids Res 30, 3233-3240.
Youdim MBH and Riederer P (1997) Understanding Parkinson’s
disease. Scientific Am. Jan 1997, 52-59.
Yovandich J, O'Malley Jr B, Sikes M, Ledley FD (1995) Gene
transfer to synovial cells by intra-articular administration of
plasmid DNA. Hum Gene Ther 6, 603-610.
Yu D, Matin A, Xia W, Sorgi F, Huang L, Hung MC (1995)
Liposome-mediated in vivo E1A gene transfer suppressed
dissemination of ovarian cancer cells that overexpress HER-
2/neu. Oncogene 11, 1383-1388.
Yuan J, Shaham S, Ledoux S, Ellis HM, and Horvitz HR (1993)
The C. elegans cell death gene ced-3 encodes a protein